跳至主要内容
临床试验/NCT04868526
NCT04868526招募中不适用

Dietary Intervention to Mitigate Adverse Consequences of Night Work

Brigham and Women's Hospital2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2023年3月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
24
试验地点
2
主要终点
Change in glucose tolerance from Baseline to Test Day

研究概览

简要总结

The goal of this clinical trial is to test whether our dietary intervention can prevent or lessen the negative health effects of night shift work in healthy participants.

Participants will:

  • complete 2 inpatient stays
  • be provided with identical meals
  • have frequent blood draws
  • provide urine, saliva, stool and rectal swab samples

详细描述

Shift work increases the risk for diabetes possibly due to the adverse metabolic effects of circadian misalignment. As shift work is not foreseen to disappear, the development of individually-targeted therapies for metabolic health in these vulnerable shift workers is urgently needed. This research will determine whether our dietary intervention can mitigate the adverse metabolic effects of circadian misalignment, which may help in the design of evidence-based dietary interventions to improve the metabolic health in shift workers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18-45 yr old
  • BMI 20.0-29.9
  • European/Hispanic/African-American ancestry
  • No acute, chronic or debilitating medical conditions (e.g. metabolic, cardiovascular, respiratory, neurological, cancers, etc.)

排除标准

  • Currently smoking/vaping or 5 or more years of smoking/vaping
  • History of drug or alcohol dependency
  • History of psychiatric illness or disorder

结局指标

主要结局

Change in glucose tolerance from Baseline to Test Day

时间窗: Baseline (Day 2) and Test Day (Day 4)

Change in incremental glucose area under the curve (AUC) from a mixed meal test.

Changes in microbial community structure/composition/function of oral and gut microbiome from Baseline to Test Day

时间窗: Baseline (Day 2) and Test Day (Day 4)

Shotgun metagenomics sequencing or 16S rRNA sequencing of saliva, stool, and rectal swab samples will provide in-depth interrogation of the microbial community structure, composition, and function.

次要结局

  • Change in levels of serum markers of gut microbiota from Baseline to Test Day(Baseline (Day 2) and Test Day (Day 4))
  • Change in level of serum markers of inflammatory state from Baseline to Test Day(Baseline (Day 2) and Test Day (Day 4))
  • Change in insulin sensitivity (Oral Minimal Model method) from Baseline to Test Day(Baseline (Day 2) and Test Day (Day 4))
  • Change in levels of serum markers of intestinal barrier integrity from Baseline to Test Day(Baseline (Day 2) and Test Day (Day 4))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Frank AJL Scheer, PhD

Professor

Brigham and Women's Hospital

研究点 (2)

Loading locations...

相似试验